Synaptoprotection in Perinatal Asphyxia: An Experimental Approach

Chromosomal aberrations in Perinatal Asphyxia

This study was conducted to evaluate the level of chromosomal damage in perinatal asphyxia and correlate it with severity of asphyxia. Fourty term neonates with asphyxia and twenty term babies without asphyxia were included in this case control study. Blood samples were collected within 24 hours of birth for karyotyping and oxidative stress by serum malondealdehyde (MDA) estimation. The degree ...

Cardiac Function in Perinatal Asphyxia

At present no clear-cut physiologic/serological parameter exist which enable an early identification of neonates who are at increased risk to develop myocardial dysfunction in perinatal asphyxia. This study was conducted to find out the incidence and features of cardiac dysfunction in perinatal asphyxia The present study was carried out on 48 neonates ,17 healthy neonates were taken as controls...

On Evaluation of Organ Damage in Perinatal Asphyxia: an Experimental and Clinical Study

Neurological Complications of Perinatal Asphyxia

The degree of asphyxia is best ascertained by measuring the amount of fetal acidosis determined by umbilical arterial blood. An umbilical arterial pH of less than 7.0 is seen in about 0.3% of deliveries.1 It indicates a severity of acidosis that places the fetus at risk for permanent neurological damage because of asphyxia. However, the outcome of infants with umbilical cord pH of less than 7.0...

Neuroprotective treatment for perinatal asphyxia.

BACKGROUND Perinatal asphyxia can cause serious illness or death. By taking steps in the «latent phase», which occurs 6-24 hours after the hypoxic event, the neurological damage caused by perinatal asphyxia can be limited. We wish to present a selection of such measures that are either established treatment today or that appear promising. METHOD We searched in the Medline and Cochrane Library...